Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medulloblastoma | 21 | 2023 | 682 | 3.170 |
Why?
|
DNA Methylation | 45 | 2024 | 4419 | 1.830 |
Why?
|
Cerebellar Neoplasms | 14 | 2023 | 590 | 1.580 |
Why?
|
Brain Neoplasms | 39 | 2024 | 9197 | 1.110 |
Why?
|
Astrocytoma | 10 | 2023 | 780 | 0.920 |
Why?
|
Isocitrate Dehydrogenase | 12 | 2023 | 954 | 0.690 |
Why?
|
Ependymoma | 7 | 2023 | 328 | 0.670 |
Why?
|
Glioma | 12 | 2024 | 3526 | 0.630 |
Why?
|
Single-Cell Analysis | 8 | 2024 | 2533 | 0.550 |
Why?
|
DNA Copy Number Variations | 12 | 2024 | 2046 | 0.550 |
Why?
|
Glioblastoma | 13 | 2024 | 3526 | 0.530 |
Why?
|
Histones | 12 | 2021 | 2593 | 0.500 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2024 | 8628 | 0.490 |
Why?
|
Central Nervous System Neoplasms | 7 | 2020 | 930 | 0.490 |
Why?
|
Epigenesis, Genetic | 13 | 2024 | 3826 | 0.480 |
Why?
|
Genomics | 9 | 2024 | 5916 | 0.430 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1795 | 0.410 |
Why?
|
Mutation | 33 | 2023 | 30230 | 0.410 |
Why?
|
Chromosomes, Human, Pair 1 | 5 | 2024 | 640 | 0.390 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 4 | 2019 | 494 | 0.380 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2020 | 3794 | 0.360 |
Why?
|
Neuroectodermal Tumors, Primitive | 3 | 2016 | 137 | 0.340 |
Why?
|
Gene Silencing | 3 | 2021 | 1501 | 0.340 |
Why?
|
DEAD-box RNA Helicases | 6 | 2019 | 384 | 0.320 |
Why?
|
Sequence Analysis, DNA | 6 | 2017 | 4774 | 0.320 |
Why?
|
Ribonuclease III | 3 | 2019 | 270 | 0.280 |
Why?
|
Pinealoma | 2 | 2018 | 52 | 0.270 |
Why?
|
Oncogenes | 5 | 2023 | 1234 | 0.270 |
Why?
|
Neoplasms, Neuroepithelial | 2 | 2016 | 43 | 0.260 |
Why?
|
Neoplasm Proteins | 7 | 2018 | 3609 | 0.260 |
Why?
|
Telomerase | 6 | 2017 | 752 | 0.260 |
Why?
|
Cell Lineage | 5 | 2023 | 2574 | 0.260 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 4 | 2023 | 368 | 0.250 |
Why?
|
CpG Islands | 8 | 2021 | 1208 | 0.250 |
Why?
|
Rhabdoid Tumor | 3 | 2016 | 211 | 0.250 |
Why?
|
Neurilemmoma | 3 | 2016 | 524 | 0.250 |
Why?
|
Sequence Analysis, RNA | 9 | 2020 | 2038 | 0.250 |
Why?
|
Hedgehog Proteins | 4 | 2021 | 770 | 0.250 |
Why?
|
Epigenomics | 6 | 2019 | 959 | 0.220 |
Why?
|
Eye Neoplasms | 2 | 2016 | 306 | 0.220 |
Why?
|
Sulfites | 2 | 2021 | 83 | 0.210 |
Why?
|
Metencephalon | 1 | 2022 | 2 | 0.210 |
Why?
|
Gene Expression Profiling | 17 | 2019 | 9508 | 0.210 |
Why?
|
Brain Stem Neoplasms | 2 | 2016 | 191 | 0.210 |
Why?
|
Transcription Factors | 12 | 2017 | 12166 | 0.200 |
Why?
|
Meningioma | 2 | 2024 | 1221 | 0.200 |
Why?
|
Nuclear Proteins | 9 | 2018 | 5802 | 0.200 |
Why?
|
Child | 38 | 2023 | 80894 | 0.200 |
Why?
|
Meningeal Neoplasms | 2 | 2024 | 1253 | 0.200 |
Why?
|
Burkitt Lymphoma | 2 | 2015 | 337 | 0.190 |
Why?
|
Genome | 3 | 2021 | 1747 | 0.190 |
Why?
|
DNA Modification Methylases | 6 | 2018 | 209 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2024 | 9433 | 0.190 |
Why?
|
Neurofibromatoses | 2 | 2016 | 300 | 0.180 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2021 | 73 | 0.180 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2021 | 2524 | 0.180 |
Why?
|
Wnt Proteins | 3 | 2021 | 724 | 0.180 |
Why?
|
Germinal Center | 2 | 2021 | 380 | 0.180 |
Why?
|
Enhancer Elements, Genetic | 3 | 2019 | 1368 | 0.180 |
Why?
|
Neurons | 6 | 2024 | 9512 | 0.180 |
Why?
|
Neoplasms | 4 | 2024 | 22389 | 0.170 |
Why?
|
Child, Preschool | 22 | 2019 | 42654 | 0.170 |
Why?
|
DNA Repair Enzymes | 6 | 2018 | 346 | 0.170 |
Why?
|
Humans | 91 | 2024 | 768298 | 0.170 |
Why?
|
Promoter Regions, Genetic | 7 | 2017 | 5800 | 0.170 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2741 | 0.160 |
Why?
|
Choroid Plexus Neoplasms | 2 | 2016 | 38 | 0.160 |
Why?
|
Cerebellum | 3 | 2023 | 1514 | 0.160 |
Why?
|
Cell Line, Tumor | 12 | 2024 | 17132 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3666 | 0.160 |
Why?
|
Mice | 17 | 2024 | 82004 | 0.150 |
Why?
|
MicroRNAs | 4 | 2019 | 3794 | 0.150 |
Why?
|
Pineal Gland | 2 | 2018 | 158 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2023 | 2846 | 0.150 |
Why?
|
Genome, Human | 6 | 2018 | 4450 | 0.150 |
Why?
|
Ultraviolet Rays | 1 | 2023 | 1100 | 0.150 |
Why?
|
Prognosis | 14 | 2024 | 30020 | 0.150 |
Why?
|
Sarcoma | 3 | 2021 | 1806 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2017 | 4120 | 0.150 |
Why?
|
Kruppel-Like Transcription Factors | 3 | 2017 | 507 | 0.150 |
Why?
|
Infant | 17 | 2019 | 36512 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1622 | 0.140 |
Why?
|
Gene Duplication | 1 | 2018 | 315 | 0.140 |
Why?
|
Tumor Microenvironment | 3 | 2019 | 3940 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5335 | 0.140 |
Why?
|
Infratentorial Neoplasms | 1 | 2017 | 99 | 0.140 |
Why?
|
DNA-Binding Proteins | 6 | 2017 | 9618 | 0.140 |
Why?
|
DNA Helicases | 4 | 2014 | 853 | 0.130 |
Why?
|
Neuroectodermal Tumors | 1 | 2016 | 23 | 0.130 |
Why?
|
Papilloma, Choroid Plexus | 1 | 2016 | 9 | 0.130 |
Why?
|
Teratoma | 2 | 2016 | 405 | 0.130 |
Why?
|
Ataxia Telangiectasia | 1 | 2017 | 107 | 0.130 |
Why?
|
Muscle Proteins | 2 | 2018 | 1165 | 0.130 |
Why?
|
Animals | 18 | 2024 | 169322 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2023 | 3620 | 0.120 |
Why?
|
Genomic Instability | 2 | 2017 | 715 | 0.120 |
Why?
|
Nerve Tissue Proteins | 2 | 2021 | 4414 | 0.120 |
Why?
|
Adolescent | 22 | 2023 | 89182 | 0.120 |
Why?
|
Workflow | 1 | 2020 | 859 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 620 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1753 | 0.120 |
Why?
|
Genes, p16 | 1 | 2015 | 160 | 0.120 |
Why?
|
Supratentorial Neoplasms | 1 | 2016 | 159 | 0.120 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5857 | 0.120 |
Why?
|
Algorithms | 5 | 2024 | 14154 | 0.120 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 170 | 0.120 |
Why?
|
Lymphoma, B-Cell | 1 | 2021 | 945 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2018 | 540 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 7 | 2018 | 2811 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2014 | 80 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 7 | 2019 | 6541 | 0.110 |
Why?
|
Glutamic Acid | 1 | 2019 | 1193 | 0.110 |
Why?
|
Pyrophosphatases | 1 | 2014 | 142 | 0.110 |
Why?
|
Immunohistochemistry | 5 | 2018 | 11117 | 0.110 |
Why?
|
Gene Deletion | 2 | 2018 | 2673 | 0.110 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2012 | 17 | 0.110 |
Why?
|
Oligodendroglioma | 1 | 2014 | 278 | 0.110 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2014 | 205 | 0.110 |
Why?
|
Biological Specimen Banks | 1 | 2018 | 782 | 0.100 |
Why?
|
Chordoma | 1 | 2016 | 349 | 0.100 |
Why?
|
Chromatin | 3 | 2014 | 2967 | 0.100 |
Why?
|
Female | 44 | 2024 | 397050 | 0.100 |
Why?
|
Transaminases | 1 | 2013 | 199 | 0.100 |
Why?
|
Receptor, trkB | 1 | 2013 | 125 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2018 | 3616 | 0.100 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2016 | 731 | 0.100 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8562 | 0.100 |
Why?
|
Protein Phosphatase 1 | 1 | 2012 | 135 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 808 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 259 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1166 | 0.100 |
Why?
|
Dendritic Cells | 1 | 2023 | 2749 | 0.100 |
Why?
|
Cell Proliferation | 6 | 2022 | 10464 | 0.100 |
Why?
|
Methylation | 4 | 2016 | 1076 | 0.100 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4921 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 855 | 0.090 |
Why?
|
Male | 39 | 2024 | 364870 | 0.090 |
Why?
|
Adult | 26 | 2024 | 223622 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2018 | 2058 | 0.090 |
Why?
|
Disease-Free Survival | 6 | 2017 | 6856 | 0.090 |
Why?
|
GTPase-Activating Proteins | 1 | 2014 | 470 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2015 | 460 | 0.090 |
Why?
|
RNA Stability | 1 | 2013 | 321 | 0.090 |
Why?
|
Survival Analysis | 6 | 2024 | 10117 | 0.090 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 269 | 0.090 |
Why?
|
Cell Differentiation | 4 | 2021 | 11659 | 0.090 |
Why?
|
Recurrence | 2 | 2019 | 8501 | 0.090 |
Why?
|
Software | 1 | 2024 | 4452 | 0.080 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1248 | 0.080 |
Why?
|
Gene Library | 1 | 2012 | 1061 | 0.080 |
Why?
|
Skin | 1 | 2023 | 4499 | 0.080 |
Why?
|
Repressor Proteins | 3 | 2016 | 2986 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2021 | 1889 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2536 | 0.080 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2014 | 350 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2094 | 0.080 |
Why?
|
Base Sequence | 6 | 2019 | 12421 | 0.080 |
Why?
|
Signal Transduction | 8 | 2021 | 23629 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1410 | 0.080 |
Why?
|
Estrogen Receptor alpha | 1 | 2012 | 580 | 0.080 |
Why?
|
Binding Sites | 2 | 2014 | 6018 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2565 | 0.080 |
Why?
|
Germany | 3 | 2016 | 882 | 0.080 |
Why?
|
Tamoxifen | 1 | 2012 | 968 | 0.080 |
Why?
|
Cluster Analysis | 4 | 2017 | 2727 | 0.070 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1019 | 0.070 |
Why?
|
Disease Progression | 4 | 2019 | 13646 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1558 | 0.070 |
Why?
|
Specimen Handling | 1 | 2012 | 707 | 0.070 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 632 | 0.070 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 2 | 2021 | 103 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11254 | 0.070 |
Why?
|
Young Adult | 14 | 2018 | 60048 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2016 | 17626 | 0.070 |
Why?
|
Genes, Immunoglobulin | 2 | 2021 | 286 | 0.070 |
Why?
|
Neural Stem Cells | 1 | 2014 | 891 | 0.070 |
Why?
|
Middle Aged | 21 | 2024 | 223463 | 0.070 |
Why?
|
Zebrafish | 2 | 2016 | 3037 | 0.070 |
Why?
|
Transcription, Genetic | 3 | 2015 | 7599 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2021 | 12801 | 0.060 |
Why?
|
Proteomics | 1 | 2019 | 3906 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2018 | 18047 | 0.060 |
Why?
|
Chromosome Deletion | 2 | 2024 | 1390 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4526 | 0.060 |
Why?
|
RNA-Binding Proteins | 1 | 2014 | 1883 | 0.060 |
Why?
|
Genes, myc | 2 | 2019 | 391 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2340 | 0.060 |
Why?
|
Neurofibromin 1 | 2 | 2016 | 190 | 0.060 |
Why?
|
Principal Component Analysis | 2 | 2017 | 948 | 0.060 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2414 | 0.050 |
Why?
|
Chromosomes, Human | 2 | 2017 | 444 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2019 | 1748 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20224 | 0.050 |
Why?
|
Age Factors | 2 | 2018 | 18472 | 0.050 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2014 | 534 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3612 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3541 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 314 | 0.050 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2015 | 1614 | 0.050 |
Why?
|
Gene Dosage | 2 | 2015 | 1221 | 0.040 |
Why?
|
HEK293 Cells | 3 | 2016 | 4286 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2911 | 0.040 |
Why?
|
Receptors, Cell Surface | 3 | 2015 | 2819 | 0.040 |
Why?
|
Histone Code | 1 | 2021 | 160 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2021 | 375 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2019 | 16027 | 0.040 |
Why?
|
Oncogene Proteins | 2 | 2014 | 718 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 1967 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1671 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2014 | 1839 | 0.040 |
Why?
|
Cohort Studies | 6 | 2021 | 41791 | 0.040 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2019 | 108 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 637 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2021 | 656 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2015 | 2950 | 0.040 |
Why?
|
Aged | 11 | 2024 | 171544 | 0.040 |
Why?
|
Mice, SCID | 2 | 2014 | 2632 | 0.040 |
Why?
|
Chromosome Aberrations | 2 | 2015 | 1780 | 0.040 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1395 | 0.040 |
Why?
|
Pons | 1 | 2019 | 242 | 0.040 |
Why?
|
Organ Specificity | 1 | 2023 | 1966 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2020 | 558 | 0.040 |
Why?
|
Orphan Nuclear Receptors | 1 | 2018 | 63 | 0.040 |
Why?
|
beta Catenin | 2 | 2014 | 1047 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 427 | 0.040 |
Why?
|
Cell Death | 1 | 2023 | 1681 | 0.040 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2017 | 44 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13696 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2461 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2013 | 7885 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9506 | 0.030 |
Why?
|
Austria | 1 | 2016 | 209 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2022 | 1748 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2017 | 267 | 0.030 |
Why?
|
Melanoma | 1 | 2014 | 5705 | 0.030 |
Why?
|
Switzerland | 1 | 2016 | 323 | 0.030 |
Why?
|
Neurofibromin 2 | 1 | 2017 | 271 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18358 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 65365 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2021 | 4785 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 636 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 351 | 0.030 |
Why?
|
Lysine | 1 | 2019 | 988 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3092 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 710 | 0.030 |
Why?
|
Cell Cycle | 2 | 2013 | 2934 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2012 | 21163 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2018 | 59683 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2482 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 749 | 0.030 |
Why?
|
Synaptophysin | 1 | 2014 | 140 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
Rhombencephalon | 1 | 2014 | 81 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2016 | 395 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2014 | 182 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 861 | 0.030 |
Why?
|
Cytodiagnosis | 1 | 2017 | 452 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15593 | 0.030 |
Why?
|
Liposarcoma, Myxoid | 1 | 2013 | 60 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2013 | 93 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2017 | 737 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1779 | 0.030 |
Why?
|
Genes, Developmental | 1 | 2013 | 38 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 348 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2012 | 3436 | 0.030 |
Why?
|
Dacarbazine | 1 | 2016 | 560 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 384 | 0.030 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2013 | 52 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 2016 | 499 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2018 | 81768 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1337 | 0.030 |
Why?
|
NIH 3T3 Cells | 1 | 2014 | 669 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2013 | 189 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13425 | 0.030 |
Why?
|
Survival Rate | 2 | 2017 | 12870 | 0.030 |
Why?
|
Gene Fusion | 1 | 2015 | 356 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2016 | 618 | 0.020 |
Why?
|
Ontario | 1 | 2013 | 403 | 0.020 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 370 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2012 | 286 | 0.020 |
Why?
|
Polyploidy | 1 | 2012 | 120 | 0.020 |
Why?
|
Metabolism | 1 | 2013 | 193 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2016 | 1524 | 0.020 |
Why?
|
Phenotype | 3 | 2014 | 16716 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 190 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 712 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 453 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2013 | 856 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1628 | 0.020 |
Why?
|
Neurofibromatosis 2 | 1 | 2014 | 384 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2862 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2012 | 329 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2017 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1280 | 0.020 |
Why?
|
Cilia | 1 | 2014 | 499 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 997 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1232 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4584 | 0.020 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 473 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2012 | 322 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 13019 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1118 | 0.020 |
Why?
|
Prospective Studies | 3 | 2022 | 54921 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2877 | 0.020 |
Why?
|
Radiotherapy | 1 | 2016 | 1509 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2013 | 697 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1356 | 0.020 |
Why?
|
RNA | 1 | 2019 | 2726 | 0.020 |
Why?
|
World Health Organization | 1 | 2015 | 1327 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1408 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2014 | 1026 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2929 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3107 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1169 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1374 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2011 | 1992 | 0.020 |
Why?
|
DNA Repair | 1 | 2017 | 2050 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2013 | 873 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2012 | 762 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3630 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2014 | 1249 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1145 | 0.020 |
Why?
|
Trans-Activators | 1 | 2016 | 2855 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1492 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2204 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2015 | 2448 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6808 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3345 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2830 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12775 | 0.020 |
Why?
|
Telomere | 1 | 2012 | 943 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14736 | 0.020 |
Why?
|
Protein Conformation | 1 | 2013 | 3957 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5033 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2012 | 6132 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2884 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2012 | 1536 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2012 | 4622 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2630 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 13038 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2013 | 2593 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2836 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4940 | 0.010 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2011 | 1094 | 0.010 |
Why?
|
Pediatrics | 1 | 2018 | 3624 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4031 | 0.010 |
Why?
|
Gene Expression | 1 | 2016 | 7595 | 0.010 |
Why?
|
Models, Molecular | 1 | 2013 | 5408 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3631 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2247 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2889 | 0.010 |
Why?
|
Macrophages | 1 | 2017 | 5796 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9635 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4352 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9346 | 0.010 |
Why?
|
Brain | 2 | 2019 | 27452 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2588 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12092 | 0.010 |
Why?
|
Risk Factors | 2 | 2016 | 74954 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14481 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2013 | 12557 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 22292 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 19019 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9494 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11854 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11914 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24316 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8764 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39405 | 0.010 |
Why?
|
Time Factors | 1 | 2013 | 40267 | 0.010 |
Why?
|